Clinical Trial Update: Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on using fulvestrant and/or anastrozole in postmenopausal patients with Stage II–III breast cancer undergoing surgery; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Faslodex (fulvestrant)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING